1-9 of 9
Peter Lee
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pembrolizumab plus vorinostat induces responses in patients with Hodgkin lymphoma refractory to prior PD-1 blockade

Clinical Trials & Observations
Matthew Mei, Lu Chen, James Godfrey, Joo Song, Colt Egelston, Sandrine Puverel, L. Elizabeth Budde, Saro Armenian, Liana Nikolaenko, Mary Nwangwu, Weihua Guo, Lei Gao, Peter Lee, Robert Chen, Shari Daniels, Neena Kennedy, Lacolle Peters, Jasmine Zain, Steven Rosen, Stephen Forman, Leslie Popplewell, Larry Kwak, Alex F. Herrera
Journal: Blood
Blood (2023) 142 (16): 1359–1370.
https://doi.org/10.1182/blood.2023020485
Published: 2023
Includes: Supplemental data
Journal Articles

Update On The Long-Term Efficacy and Safety Of Momelotinib, a JAK1 and JAK2 Inhibitor, For The Treatment Of Myelofibrosis

Animesh Pardanani, MBBS, PhD, Jason Gotlib, MD, MS, Vikas Gupta, MD, FRCP, FRCPath, Andrew W. Roberts, MBBS, PhD, Martha Wadleigh, MD, Shireen Sirhan, MD, FRCP, Linda M Bavisotto, MD, Jun Kawashima, MD, Peter Lee, MD, PhD, Mark Kowalski, MD, PhD, Wei Deng, PhD, Demi Niforos, MS, Ayalew Tefferi, MD
Journal: Blood
Blood (2013) 122 (21): 108.
https://doi.org/10.1182/blood.V122.21.108.108
Published: 2013
Journal Articles

An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma

Clinical Trials & Observations
Ravi Vij, Michael Wang, Jonathan L. Kaufman, Sagar Lonial, Andrzej J. Jakubowiak, A. Keith Stewart, Vishal Kukreti, Sundar Jagannath, Kevin T. McDonagh, Melissa Alsina, Nizar J. Bahlis, Frederic J. Reu, Nashat Y. Gabrail, Andrew Belch, Jeffrey V. Matous, Peter Lee, Peter Rosen, Michael Sebag, David H. Vesole, Lori A. Kunkel, Sandra M. Wear, Alvin F. Wong, Robert Z. Orlowski, David S. Siegel
Journal: Blood
Blood (2012) 119 (24): 5661–5670.
https://doi.org/10.1182/blood-2012-03-414359
Published: 2012
Journal Articles

Final Results From the Bortezomib-naïve Group of PX-171-004, a Phase 2 Study of Single-Agent Carfilzomib in Patients with Relapsed and/or Refractory MM

Ravi Vij, MD, Jonathan L. Kaufman, MD, Andrzej J Jakubowiak, MD, PhD, Michael Wang, MD, Sundar Jagannath, MD, Vishal Kukreti, MD, FRCPC, Kevin T. McDonagh, MD, Melissa Alsina, MD, Nizar J Bahlis, MD, Andrew R Belch, MD, Frederic J. Reu, MD, Nashat Y. Gabrail, MD, Jeffrey Matous, MD, David H. Vesole, MD, PhD, Robert Z. Orlowski, MD, PhD, Sandra Wear, RN, Lori Kunkel, MD, Alvin F. Wong, PharmD, Peter Lee, MD, PhD, Keith Stewart, MBA, MB, CHB
Journal: Blood
Blood (2011) 118 (21): 813.
https://doi.org/10.1182/blood.V118.21.813.813
Published: 2011
Journal Articles

The HDAC Inhibitor Entinostat (SNDX-275) Induces Clinical Responses in Patients with Relapsed and Refractory Hodgkin's Lymphoma: Results of ENGAGE-501 Multicenter Phase 2 Study

Anas Younes, MD, Francisco Hernandez, M.D., R. Gregory Bociek, MD, Yvette L. Kasamon, Peter Lee, MD, PhD, Lia Gore, MD, Amanda R Copeland, MSN, RN, CSN
Journal: Blood
Blood (2011) 118 (21): 2715.
https://doi.org/10.1182/blood.V118.21.2715.2715
Published: 2011
Journal Articles

A Phase 1b/2 Study of Prolonged Infusion Carfilzomib in Patients with Relapsed and/or Refractory (R/R) Multiple Myeloma: Updated Efficacy and Tolerability From the Completed 20/56mg/m 2 Expansion Cohort of PX-171-007

Kyriakos P Papadopoulos, MD, Peter Lee, MD, PhD, Seema Singhal, MD, Joseph R. Holahan, MD, David H. Vesole, MD, PhD, Steven T. Rosen, MD, FRCPA, Lori Kunkel, MD, Alison L. Hannah, MD, David S. Siegel, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2930.
https://doi.org/10.1182/blood.V118.21.2930.2930
Published: 2011
Journal Articles

Carfilzomib: High Single Agent Response Rate with Minimal Neuropathy Even In High-Risk Patients

Ravi Vij, MBBS, MD, Jonathan L. Kaufman, MD, Andrzej J Jakubowiak, MD, PhD, A. Keith Stewart, MBChB, Sundar Jagannath, MD, Vishal Kukreti, MD, FRCPC, Kevin T. McDonagh, MD, Melissa Alsina, MD, Nizar J Bahlis, MD, Andrew Belch, MD, Frederic J. Reu, MD, Nashat Y Gabrail, MD, Jeffrey Matous, MD, David H. Vesole, MD, PhD, Robert Z. Orlowski, MD, PhD, Mai H. Le, MD, Peter Lee, MD, PhD, Michael Wang, MD, The MMRC
Journal: Blood
Blood (2010) 116 (21): 1938.
https://doi.org/10.1182/blood.V116.21.1938.1938
Published: 2010
Journal Articles

ENGAGE- 501: Phase 2 Study Investigating the Role of Epigenetic Therapy with Entinostat (SNDX-275) In Relapsed and Refractory Hodgkin's Lymphoma (HL), Interim Results

Anas Younes, MD, Francisco Hernandez, R. Gregory Bociek, MD, Yvette L. Kasamon, Peter Lee, MD, PhD, Lia Gore, MD, Daniela Buglio, MD, PhD, Amanda Copeland
Journal: Blood
Blood (2010) 116 (21): 3959.
https://doi.org/10.1182/blood.V116.21.3959.3959
Published: 2010
Journal Articles

Phase 1b Evaluation of the Safety and Efficacy of a 30-Minute IV Infusion of Carfilzomib In Patients with Relapsed and/or Refractory Multiple Myeloma

Kyriakos Papadopoulos, MD, David Samuel diCapua Siegel, MD, PhD, Seema B. Singhal, MD, Jeffrey R. Infante, MD, Edward A. Sausville, MD, PhD, Michael S. Gordon, MD, Michael Kauffman, MD, PhD, Tina Woo, Susan Lee, Lynne Bui, MD, Alison L. Hannah, MD, Peter Lee, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3024.
https://doi.org/10.1182/blood.V116.21.3024.3024
Published: 2010